Sun Pharmaceutical Industries and its subsidiaries or associate companies (Sun Pharma) along with Indian Council of Medical Research (ICMR), Ministry of Health & Family Welfare (MOHFW), Government of India, Government of Madhya Pradesh, have announced India’s first public-private-partnership agreement for Malaria Free India and other innovation in preventive health.
Under the aegis of this unique public-private-partnership, ICMR, MOHFW, Government of India, Government of Madhya Pradesh and Sun Pharma will establish a malaria elimination demonstration project titled Malaria Free India, to support the national framework for elimination of malaria in India.
The demonstration project will be launched in one of the most malaria endemic districts of Madhya Pradesh and implemented in a phased manner, beginning with Mandla district of Madhya Pradesh. The public-private-partnership stakeholders will execute the malaria elimination programme over a span of 3 to 5 years covering over 1,200 villages in Mandla district.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1674.00 |
| Dr. Reddys Lab | 1224.90 |
| Cipla | 1230.50 |
| Zydus Lifesciences | 931.00 |
| Lupin | 2335.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: